MYC and acute myeloid leukemia: Dysregulation of key leukemogenic drivers, such as MYC, HOXA, and MEIS1, triggers a cascade of carcinogenic events in AML (Luo et al., 2005; Xie et al., 2025; Zhou and Lu, 2023), and SEs play a central role in these dysregulation.